Jun 07, 2016 06:00 AM EDT
Chimeric Antigen Receptor T-Cell (CAR-T) Therapies Set To Gain Approval By 2017
A new kind of therapy aimed at addressing an immune system’s powerful T-cells could be out as early as next year if two pharmaceutical companies regulatory approval gains ground.
